In focus · trending topic

tumor

13 stories · following the connections

VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients

By Nasdaq OMXApr 17, 2018, 12:01 PM UTC

Research to Determine If Eating Broccoli Sprouts Can Help Reduce the Development of Cancerous Colon Tumors

By Nasdaq OMXFeb 12, 2018, 11:30 AM UTC

ASLAN Pharmaceuticals Appoints Stephen Doyle as Head of China

By Nasdaq OMXJan 18, 2018, 6:00 AM UTC

VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901

By Nasdaq OMXJan 17, 2018, 1:00 PM UTC

ASLAN Pharmaceuticals Announces Shortened Timeline to Commercialisation for Varlitinib in China

By Nasdaq OMXJan 8, 2018, 6:00 AM UTC

ASLAN Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

By Nasdaq OMXJan 4, 2018, 7:00 AM UTC

ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for Varlitinib From Array BioPharma

By Nasdaq OMXJan 3, 2018, 8:00 AM UTC

Clinical Data for eFFECTOR Therapeutics’ Lead Candidate eFT508 Demonstrates Clinical Activity, Well-Tolerated Safety Profile

By Nasdaq OMXDec 11, 2017, 3:00 PM UTC